Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Bioavailability and Food-Effect Study of Ensitrelvir Granules vs 125 mg Tablets in Healthy Japanese Adults
jRCT2031240587Phase 1Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ensitrelvir in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Pharmacokinetic parameters. Started Dec 2024; status: recruiting.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031240587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240587.